The biology of incretin hormones - PubMed (original) (raw)

Review

The biology of incretin hormones

Daniel J Drucker. Cell Metab. 2006 Mar.

Free article

Abstract

Gut peptides, exemplified by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are secreted in a nutrient-dependent manner and stimulate glucose-dependent insulin secretion. Both GIP and GLP-1 also promote beta cell proliferation and inhibit apoptosis, leading to expansion of beta cell mass. GLP-1, but not GIP, controls glycemia via additional actions on glucose sensors, inhibition of gastric emptying, food intake and glucagon secretion. Furthermore, GLP-1, unlike GIP, potently stimulates insulin secretion and reduces blood glucose in human subjects with type 2 diabetes. This article summarizes current concepts of incretin action and highlights the potential therapeutic utility of GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes.

PubMed Disclaimer

Similar articles

• The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
  Edholm T, Cejvan K, Abdel-Halim SM, Efendic S, Schmidt PT, Hellström PM. Edholm T, et al. Neurogastroenterol Motil. 2009 Mar;21(3):313-21. doi: 10.1111/j.1365-2982.2008.01229.x. Epub 2008 Dec 18. Neurogastroenterol Motil. 2009. PMID: 19126188
• What do we know about the secretion and degradation of incretin hormones?
  Deacon CF. Deacon CF. Regul Pept. 2005 Jun 15;128(2):117-24. doi: 10.1016/j.regpep.2004.06.007. Regul Pept. 2005. PMID: 15780431 Review.
• [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
  Diamant M, Bunck MC, Heine RJ. Diamant M, et al. Ned Tijdschr Geneeskd. 2004 Sep 25;148(39):1912-7. Ned Tijdschr Geneeskd. 2004. PMID: 15495988 Review. Dutch.
• Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.
  Freeman JS. Freeman JS. Cleve Clin J Med. 2009 Dec;76 Suppl 5:S12-9. doi: 10.3949/ccjm.76.s5.03. Cleve Clin J Med. 2009. PMID: 19952298 Review.
• A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
  Green BD, Gault VA, O'Harte FP, Flatt PR. Green BD, et al. Diabetes Obes Metab. 2005 Sep;7(5):595-604. doi: 10.1111/j.1463-1326.2004.00455.x. Diabetes Obes Metab. 2005. PMID: 16050953

Cited by

• Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism.
  Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W, Liu Z. Chai W, et al. Diabetes. 2012 Apr;61(4):888-96. doi: 10.2337/db11-1073. Epub 2012 Feb 22. Diabetes. 2012. PMID: 22357961 Free PMC article.
• GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.
  Lu SC, Chen M, Atangan L, Killion EA, Komorowski R, Cheng Y, Netirojjanakul C, Falsey JR, Stolina M, Dwyer D, Hale C, Stanislaus S, Hager T, Thomas VA, Harrold JM, Lloyd DJ, Véniant MM. Lu SC, et al. Cell Rep Med. 2021 Apr 30;2(5):100263. doi: 10.1016/j.xcrm.2021.100263. eCollection 2021 May 18. Cell Rep Med. 2021. PMID: 34095876 Free PMC article.
• Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
  Fu Z, Gilbert ER, Liu D. Fu Z, et al. Curr Diabetes Rev. 2013 Jan 1;9(1):25-53. Curr Diabetes Rev. 2013. PMID: 22974359 Free PMC article. Review.
• Early Effect of Single-dose Sitagliptin Administration on Gastric Emptying: Crossover Study Using the (13)C Breath Test.
  Nonaka T, Sekino Y, Iida H, Yamada E, Ohkubo H, Sakai E, Higurashi T, Hosono K, Endo H, Koide T, Takahashi H, Fujita K, Yoneda M, Goto A, Kusakabe A, Kobayashi N, Gotoh E, Maeda S, Nakajima A, Nosaka C, Inamori M. Nonaka T, et al. J Neurogastroenterol Motil. 2013 Apr;19(2):227-32. doi: 10.5056/jnm.2013.19.2.227. Epub 2013 Apr 16. J Neurogastroenterol Motil. 2013. PMID: 23667754 Free PMC article.
• Evolution of GCGR family ligand-receptor extensive cross-interaction systems suggests a therapeutic direction for hyperglycemia in mammals.
  Liu J, Wang X, Zhang W, Liao G, Shao Z, Brosius J, Deng C, Lai S, Long E. Liu J, et al. Acta Biochim Biophys Sin (Shanghai). 2023 Dec 25;55(12):1855-1863. doi: 10.3724/abbs.2023133. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37969012 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal